Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Mersana Therapeutics Inc. (MRSN)

1.87   0.03 (1.63%) 10-23 16:00
Open: 1.81 Pre. Close: 1.84
High: 1.95 Low: 1.75
Volume: 636,185 Market Cap: 89M
Mersana Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing antibody drug conjugates, or ADCs, that offer a clinically meaningful benefit for cancer patients with significant unmet need.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.952 - 1.96 1.96 - 1.967
Low: 1.732 - 1.74 1.74 - 1.748
Close: 1.856 - 1.869 1.869 - 1.883

Technical analysis

as of: 2019-10-23 4:52:44 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 2.28     One year: 2.66
Support: Support1: 1.61    Support2: 1.40
Resistance: Resistance1: 1.95    Resistance2: 2.28
Pivot: 1.61
Moving Average: MA(5): 1.75     MA(20): 1.59
MA(100): 2.91     MA(250): 4.25
MACD: MACD(12,26): -0.06     Signal(9): -0.14
Stochastic oscillator: %K(14,3): 80.57     %D(3): 68.99
RSI: RSI(14): 56.98
52-week: High: 7.65  Low: 1.40  Change(%): -69.4
Average Vol(K): 3-Month: 27258  10-Days: 33590

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
MRSN has closed above the upper band by 1.3%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 32.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Warning: file_get_contents( failed to open stream: HTTP request failed! HTTP/1.1 402 Payment Required in /home/content/81/11032181/html/www/stoxline/quote.php on line 283

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  Nasdaq Global Select
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 47.81
Shares Float (M) 24.49
% Held by Insiders
% Held by Institutions
Shares Short (K) 711
Shares Short P. Month (K)

Stock Financials

EPS -1.116
Book Value (p.s.) 2.270
PEG Ratio
Profit Margin -77.78
Operating Margin -81.88
Return on Assets (ttm) -18.5
Return on Equity (ttm) -45.0
Qtrly Rev. Growth -95.2
Gross Profit (p.s.) -1.032
Sales Per Share
EBITDA (p.s.) -0.735
Qtrly Earnings Growth
Operating Cash Flow (M) -65.26
Levered Free Cash Flow (M) -25.99

Stock Valuations

P/E -1.68
P/E Growth Ratio 0.02
P/BV 0.82
P/S 62520768.00
P/CF -1.37

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.